Investing.com AI Model Closes 87% Gain in Haemonetics Amid Portfolio Rebalancing

An AI-driven stock selection model from Investing.com has closed out several profitable U.S. equity positions, most notably banking an 86.9% gain on medical technology firm Haemonetics (NYSE:HAE). The exits are part of the ProPicks model's scheduled monthly rebalancing, which redeploys capital from positions deemed to have exhausted their near-term momentum into new opportunities.

Details of the Exits

According to an October 25, 2026, report from the platform, its AI models executed several data-driven exit signals for U.S. stocks. The most significant closed positions included:

• Haemonetics (HAE): +86.9% gain. The position was entered in September 2025 at $54.54 and exited one year later in September 2026 at $101.95.
• ON Semiconductor (ON): +51.2% gain. Entered in May 2025 at $39.60 and exited in February 2026 at $59.89.
• Commvault (CVLT): +27.3% gain. This short-term trade was entered in August 2026 at $117.80 and closed just two months later in October 2026, representing a 323% annualized rate of return.
• SM Energy (SM): +32.1% gain. The position was held from July 2026 to October 2026.

These individual results are based on the model's specific entry and exit prices and do not represent the performance of all picks. Past performance is not an indicator of future results.

Rationale Behind Key Trades

The report outlined the data-driven logic for two distinct types of trades. The Haemonetics position was a long-term holding based on a fundamental business turnaround, while the Commvault trade was designed to capture a short-term market mispricing.

Haemonetics: Turnaround and Re-rating

Ad

The AI model held Haemonetics for a full year as the company's financial performance improved. Key factors during the holding period included consistent earnings beats, organic revenue growth in its Hospital and Plasma segments, and a significant improvement in free cash flow conversion from 62% to 89%. The model exited after the stock had nearly doubled, judging that the primary re-rating phase was complete.

Commvault: Post-Earnings Momentum

In contrast, the model entered Commvault in August 2026, days after the company reported fiscal Q1 2027 earnings on July 29. The entry was based on a 20% earnings beat, rapid growth in subscription and SaaS recurring revenue, and upgraded full-year guidance. The position was closed just two months later for a 27.3% gain, capitalizing on the market's gradual repricing of the strong quarterly results.

Capital Redeployment and Strategy Performance

Cash from the closed positions was redeployed into the AI's active strategies. According to Investing.com, several of the U.S. strategies involved have outperformed their respective benchmarks year-to-date in 2026.

The 'Mid-Cap Movers' strategy, which held Haemonetics and Commvault, was reportedly up 45.9% in 2026, outperforming the S&P Midcap 400 by 36.5 percentage points. The 'Energy Elite' strategy was up 78.6%, and 'Small-Cap Sprinters' was up 34.1% for the same period.